MedCom
MedCom
Medical TopicsExpert PerspectivesToolsAbout
MedCom
Medical Topics
ENT & Hearing Health
Tinnitus: Causes, When to Worry, and What Helps

Tinnitus: Causes, When to Worry, and What Helps

9 min readSeptember 30th, 2026

Advertisement

Discover more
Get Health Tips
Health
Find Treatments
Tour Colleges
Take Med Courses
Book Care Services
Book Lab Tests
Read Med Journals

Tinnitus is the perception of sound such as ringing, buzzing, hissing, humming, whooshing, clicking, pulsing, or other noises when no external sound is present. It is a symptom, not a disease. It may be heard in one ear, both ears, or in the head; it may be constant or intermittent; and in the vast majority of cases it is subjective, meaning only the person experiencing it can hear it. Rarely, an examiner can detect an objective internal sound. That distinction matters because subjective and objective tinnitus often point to different clinical pathways.

The NHS, ENT UK, NIDCD/NIH, NICE, AAO-HNS and WHO share that core definition. They also agree that tinnitus is common in adults, that most people are only mildly affected, and that a smaller share find the sound bothersome enough to disrupt sleep, concentration, mood, or daily life. Exact prevalence figures differ by definition and population.

For many people, tinnitus is linked to hearing loss or noise exposure, but it can also occur with normal hearing. Secondary causes such as earwax, infection, certain medicines, Ménière's disease, jaw problems, vascular issues, or, less often, tumours may be identifiable and sometimes remediable. Primary tinnitus often has no clear cause beyond possible hearing change. There is no proven universal cure and no FDA-approved drug specifically for tinnitus, according to NIDCD; nonetheless, education, hearing support, psychological therapies such as cognitive behavioural therapy (CBT), and practical coping strategies can meaningfully reduce distress.

Key Takeaways

  • Tinnitus is a symptom, not a disease, and prevalence estimates from major bodies fall roughly between about 10% and 25% of adults depending on definition and population.
  • Persistent thresholds differ between organisations (≥3 months for NIDCD/WHO; ≥6 months bothersome focus in AAO-HNS guideline materials); pulsatile and unilateral tinnitus usually need a different assessment pathway.
  • There is no proven universal cure or FDA-approved tinnitus-specific drug; CBT, individualised hearing support when hearing loss is present, and sound enrichment are commonly discussed, while ginkgo, melatonin, zinc, betahistine, routine tinnitus-specific psychotropics, TMS, and intratympanic drugs for primary tinnitus are not supported by AAO-HNS/NICE guidance.

What Tinnitus Is (and What It Is Not)

A symptom, not a disease

NICE Clinical Knowledge Summaries (CKS) describe tinnitus as a symptom rather than a disease in its own right. The sound may be described as ringing, buzzing, whistling, humming, hissing, roaring, whooshing, throbbing, clicking, or less often music or indistinct speech. It can affect one or both ears or seem to come from inside the head.

Subjective, objective, primary, and secondary

  • Subjective tinnitus: heard only by the person; this is by far the most common pattern. ENT UK and NICE CKS note that objective tinnitus, detectable by an examiner, is uncommon (NICE CKS cites roughly 1% as objective).
  • Primary tinnitus: no identifiable cause beyond possible hearing loss, as described in AAO-HNS patient materials.
  • Secondary tinnitus: associated with a known or treatable cause, such as earwax, middle-ear disease, or other identifiable conditions.
  • Pulsatile tinnitus: a rhythmic sound that often beats in time with the pulse; it may reflect vascular or other internal sound generators and typically needs a different assessment pathway.

Acute, chronic, and "persistent"

Definitions of duration vary. NIDCD and WHO often describe chronic tinnitus as lasting three months or longer (WHO also contrasts acute tinnitus lasting less than three months), while AAO-HNS clinical practice guideline materials focus on bothersome tinnitus lasting six months or more when discussing persistent primary tinnitus. Neither threshold is universal.

WHO also distinguishes tinnitus (the perception of sound) from "tinnitus disorder," in which the sound is accompanied by emotional distress or cognitive dysfunction that affects quality of life. A JAMA Clinical Guidelines Synopsis notes that tinnitus is the perception of sound without an acoustic stimulus, with heterogeneous and incompletely understood pathophysiology, often linked to abnormal neural activity in the setting of hearing loss.

How Common It Is, and How Much It Can Affect Life

Prevalence estimates differ because surveys use different definitions and populations:

  • AAO-HNS patient materials estimate that tinnitus affects about 10-15% of U.S. adults, and that roughly one in five people who experience tinnitus may need clinical intervention.
  • NIDCD cites survey estimates of 10-25% of adults; children can also have tinnitus.
  • NICE public information states that tinnitus affects more than 1 in 10 adults; NICE CKS cites about 13% of UK adults with prolonged tinnitus (on the order of millions of people in the UK).
  • ENT UK estimates that about 1 in 8 of the UK population has some degree of tinnitus, while about 1 in 200 are significantly affected.

A Cochrane CBT review cites background prevalence up to about 21% of adults, with an estimated 1-3% severely affected. A JAMA synopsis describes roughly 50 million U.S. adults with tinnitus, higher rates with age, and notes that only about 20% of people with persistent tinnitus seek medical evaluation.

Impact varies widely. Many people are only mildly bothered; ENT UK notes that tinnitus may lessen or disappear over time and is rarely a sign of a serious underlying condition. Others experience insomnia, difficulty concentrating, anxiety, or depression. NICE CKS notes that severe distress can, rarely, include suicidal ideation. Emotional impact should be taken seriously. WHO distinguishes tinnitus from "tinnitus disorder," in which distress or cognitive effects impair quality of life.

Common Causes and Triggers

Exact mechanisms are incompletely understood. Tinnitus is often linked to changes in the auditory system, including hearing loss, but it can also occur with normal hearing. ENT UK explains that the brain may misinterpret random activity in the auditory pathway, and that emotional shock or a change in hearing can act as a trigger.

Frequently discussed associations

Common associations include:

  • Hearing loss: age-related (presbycusis), noise-induced, or other sensorineural loss; middle-ear disease and otosclerosis also appear in clinical lists.
  • Loud noise exposure: acute or chronic.
  • Earwax, infection, fluid, or eardrum perforation: reversible local ear problems.
  • Ménière's disease: episodic vertigo, hearing fluctuation, and tinnitus.
  • Medicines (ototoxicity): classes repeatedly mentioned include certain antibiotics, cancer (chemotherapy) drugs, NSAIDs, high-dose aspirin, antimalarials, and sometimes antidepressants.
  • Head or neck injury and jaw / temporomandibular (TMJ) problems.
  • Vascular or blood-flow issues: more often relevant to objective or pulsatile tinnitus.
  • Less common neoplastic or neurological associations: for example vestibular schwannoma (acoustic neuroma), meningioma, or multiple sclerosis.
  • Systemic conditions: diabetes, thyroid disease, anaemia, migraine, lupus, and others (NIDCD).
  • Stress, anxiety, and depression: may coexist with or amplify awareness of tinnitus; the NHS lists psychological factors among associations.

AAO-HNS materials also note associations such as older age, male sex, military service, noise exposure, cardiometabolic factors, and anxiety. These are guideline-summary associations, not single-cause proof. Many people have no clear trigger. ENT UK notes little hard evidence for food-exclusion diets as proven treatment.

When to Seek Care, and Urgent Warning Signs

Tinnitus is often not a sign of something serious, but bothersome or changing symptoms deserve clinical attention. Where to go and how quickly differs by country; the UK NHS and NICE steps that follow are local examples, not universal emergency rules.

Advertisement

When to arrange routine clinical review

Across NHS, WHO, NIDCD, and related guidance, it is reasonable to see a clinician when tinnitus is regular or constant, worsening, new, bothersome enough to disturb sleep, concentration, mood, or daily life, persisting for months (WHO highlights review especially after more than three months or when quality of life is affected), or accompanied by hearing difficulty.

NICE recommends offering audiological assessment to people with tinnitus. AAO-HNS materials emphasise prompt comprehensive hearing examination for unilateral tinnitus, bilateral tinnitus lasting six months or more in the guideline, or reported hearing difficulty.

Features that need urgent or emergency assessment

NHS advises urgent GP contact if tinnitus beats in time with the pulse, and emergency care (A&E/999 in the UK) if tinnitus occurs after a head injury, or with sudden hearing loss, facial muscle weakness, or spinning (rotational) vertigo.

NICE NG155 outlines immediate and timed referral themes that include high suicide risk; sudden significant neurological signs; acute uncontrolled vestibular symptoms; suspected stroke; sudden hearing loss of three days or less that began within the past 30 days (very urgent, about 24 hours in NICE guidance); severe distress after support has been offered, sudden hearing loss that began more than 30 days ago, or rapidly worsening hearing loss (urgent, about two weeks); and routine specialist pathways for bothersome tinnitus despite support, persistent objective tinnitus, unilateral or asymmetric hearing loss, and consideration of persistent pulsatile or persistent unilateral tinnitus.

WHO similarly advises seeing a doctor especially if tinnitus is sudden and accompanied by hearing loss, dizziness, or pain. Readers outside the UK should translate these themes into local emergency or urgent clinical pathways. When symptoms remain unsettled despite appropriate local care, some people also consider What Is a Medical Second Opinion and Why It Matters.

Pulsatile and One-Sided Tinnitus: Why They Matter

Pulsatile tinnitus

Pulsatile tinnitus is often described as a whooshing or thumping that follows the heartbeat. NHS advises urgent GP assessment when tinnitus beats with the pulse. NICE recommends offering imaging for pulsatile tinnitus and considering referral for persistent pulsatile tinnitus. NIDCD likewise notes that imaging is especially considered when tinnitus pulsates. This pattern can reflect vascular or other internal sound sources and therefore follows a different clinical pathway from typical non-pulsatile subjective tinnitus.

Unilateral tinnitus and asymmetric hearing

Persistent tinnitus in one ear, or tinnitus with asymmetric hearing loss, commonly prompts specialist pathways and imaging consideration. AAO-HNS materials generally reserve imaging for pulsatile tinnitus, focal neurological abnormalities, unilateral tinnitus, or asymmetric hearing loss. ENT UK notes that MRI is often considered for one-sided tinnitus or an asymmetric hearing test.

Neither pattern automatically means a tumour or stroke; both mean clinicians usually look more carefully for secondary causes. Sudden neurological change is a different pathway. See Stroke Warning Signs: Early Symptoms and When to Act for stroke-specific warning signs.

What You Can Try to Cope Day to Day

Self-help does not replace assessment when red flags or persistent bothersome symptoms are present, but it is a central theme in NHS, ENT UK, NICE, WHO, and NIDCD patient guidance.

Commonly recommended measures include:

  • Avoid total silence: soft background sound or sound enrichment (quiet music, a fan, nature sounds, or similar) is widely endorsed; NHS explicitly advises against sitting in complete silence and against focusing intently on the sound.
  • Night-time sound: ENT UK and WHO describe gentle background sound at night (for example a fan, soft music, or an open window where safe) to ease awareness when the environment is otherwise quiet.
  • Sleep routines: consistent sleep habits; NHS mentions reducing caffeine as part of sleep hygiene for some people, without claiming that cutting coffee "cures" tinnitus.
  • Stress reduction and relaxation: stress can heighten awareness of tinnitus; relaxation and self-help resources are repeatedly recommended.
  • Hearing protection: protect ears from loud noise and practice safe listening (NICE, WHO, NIDCD).
  • Stay engaged: continue valued activities so attention is not fixed solely on the sound (NHS, WHO).
  • Support and reliable information: support groups and trusted information; ENT UK patient material points readers toward British Tinnitus Association / Take on Tinnitus-type resources as patient-support signposts.
  • Medicine review with a clinician: if a drug is suspected as a contributor, do not stop prescribed medicines without medical advice (NHS and related guidance).

WHO notes no clear consensus that smoking, alcohol, caffeine, or obesity directly cause or cure tinnitus; lifestyle advice should not be oversold as a standalone fix.

How Clinicians Assess Tinnitus

Assessment aims to characterise the sound, identify secondary causes when present, evaluate hearing, and gauge impact on sleep, mood, and daily function.

Typical elements described across AAO-HNS, NICE, ENT UK, NHS, and NIDCD include:

  • History: onset, laterality, pulsatile vs non-pulsatile quality, associated hearing change, dizziness, ear pain or discharge, head/neck trauma, medicines, and impact on life.
  • Ear examination: to look for wax, infection, or other outer/middle-ear findings.
  • Hearing tests (audiology): NICE advises offering audiological assessment to all people with tinnitus; tympanometry and related tests may be used as clinically indicated (ENT UK).
  • Imaging: not routine for every person with tinnitus. AAO-HNS materials reserve imaging mainly for pulsatile tinnitus, focal neurological signs, unilateral tinnitus, or asymmetric hearing loss. NICE offers imaging for pulsatile tinnitus and discusses referral/imaging consideration for persistent unilateral or asymmetric presentations.
  • Mood and distress screening: because anxiety, depression, and severe distress change urgency and support needs (NICE, NHS, AAO-HNS association notes).

Findings guide whether the focus is reassurance and coping for primary tinnitus, treatment of a remediable secondary cause, or specialist investigation.

Advertisement

Treatments That Can Help

There is no proven universal cure for most primary tinnitus. NIDCD states there is no FDA-approved medication specifically for tinnitus. WHO and a JAMA Clinical Guidelines Synopsis similarly note that no definitive pharmacological cure has been established. Secondary causes such as wax or infection may improve when treated. AAO-HNS materials note that tinnitus may improve, especially when mild and present for less than six months. WHO notes that occasional longer-term remissions occur.

Education, counselling, and psychological therapies

Education and counselling are foundational (AAO-HNS, ENT UK, NICE, NHS). AAO-HNS states clinicians should recommend CBT for persistent bothersome tinnitus. NICE describes stepped psychological therapies, often starting with digital CBT, then group MBCT, ACT, or CBT, then individual CBT as needed. A 2020 Cochrane review found that CBT may reduce the negative impact of tinnitus on quality of life at the end of treatment, with low-to-moderate certainty depending on the comparison, few adverse effects, and limited longer-term follow-up evidence.

Hearing aids and sound approaches

When hearing loss affects communication, NICE advises offering amplification. NICE also says clinicians may consider amplification for hearing loss without communication difficulty, and should not offer amplification if there is no hearing loss. Suitability is individualised.

Guidance on formal sound therapy varies: AAO-HNS materials say clinicians may offer sound therapy; NICE could not make a practice recommendation from available evidence; self-help sound enrichment remains widely endorsed by NHS, ENT UK, WHO, and NIDCD. Tinnitus Retraining Therapy (TRT) is mentioned by NHS, NIDCD, and WHO; NHS notes it is unclear whether TRT works for everyone.

Treating secondary causes

Removing wax, treating infection or middle-ear disease, reviewing ototoxic medicines with a clinician, and addressing identifiable vascular or other secondary causes (especially in pulsatile cases) are part of care when relevant. Medicines used for coexisting depression, anxiety, or insomnia are different from prescribing those medicines for tinnitus itself.

Myths, Supplements, and What Usually Does Not Help

Marketing sometimes promises pills, herbs, lasers, or devices that "cure" tinnitus.

According to AAO-HNS clinical practice guideline materials, clinicians should not:

  • Routinely prescribe antidepressants, anticonvulsants, anxiolytics, or intratympanic medicines for the primary purpose of treating persistent bothersome tinnitus.
  • Recommend ginkgo biloba, melatonin, zinc, or other dietary supplements for that indication.
  • Recommend transcranial magnetic stimulation (TMS) for that indication.

AAO-HNS states there is insufficient evidence to recommend for or against acupuncture for tinnitus. NICE NG155 states clinicians should not offer betahistine to treat tinnitus. NIDCD notes that supplements advertised as cures are not proven and that no FDA-approved tinnitus-specific drug exists. WHO states that no pharmacological treatments have been shown effective for managing or resolving tinnitus.

Medicines may still be appropriate for coexisting mood or sleep problems. That is treatment of comorbidity, not a tinnitus-specific cure (NHS, NICE, NIDCD). People should be wary of products that promise guaranteed cure, and discuss any supplement or new medicine with a clinician before use.

Living With Tinnitus: Outlook and Support

Outlook depends on cause, hearing, duration, and impact. Many people with mild tinnitus adapt; ENT UK notes it may lessen or disappear, and AAO-HNS notes possible improvement when mild and relatively recent. WHO acknowledges occasional remissions while stating there is no definitive cure for most tinnitus.

Realistic goals often focus on reducing distress, protecting hearing, improving sleep, and returning attention to valued activities, not silencing the sound in every case. Support may include audiology or ENT care, psychological therapies, hearing-aid evaluation when hearing loss is present, sound enrichment, and peer support. Severe mood impact warrants timely clinical help; NICE treats high suicide risk as an emergency.

Conclusion

Tinnitus is common, usually subjective, and often linked to hearing change or noise exposure, though it can occur with normal hearing. Most people are mildly affected; a smaller share experience meaningful distress. See a clinician when tinnitus is persistent or bothersome, and use urgent local pathways for pulsatile sound, tinnitus after head injury, sudden hearing loss, facial weakness, acute uncontrolled vertigo, suspected stroke, or severe mental-health crisis. Unilateral tinnitus and asymmetric hearing loss often need specialist assessment.

There is no proven universal cure and no tinnitus-specific FDA-approved drug. Education, CBT, individualised hearing support when hearing loss is present, and sound enrichment are commonly discussed; ginkgo, melatonin, zinc, betahistine, routine tinnitus-specific psychotropics, TMS, and intratympanic drugs for primary tinnitus are not supported by AAO-HNS or NICE guidance.

Medical Disclaimer

This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Individuals should consult a qualified healthcare professional such as a primary care clinician, audiologist, or ear, nose, and throat (ENT) specialist for personal medical concerns and before changing prescribed medicines or starting new therapies. Emergency and referral timings from the NHS and NICE are UK pathways; readers should follow local emergency and clinical guidance.

Sources & References

  1. 1.
    Tinnitus (ringing in the ears)

    ENT UK • Oct 21, 2021

  2. 2.
    Clinical Practice Guideline: Tinnitus

    American Academy of Otolaryngology-Head and Neck Surgery • Oct 1, 2014

  3. 3.
    AAO-HNSF Clinical Practice Guideline: Tinnitus - Press Release & Fact Sheet

    American Academy of Otolaryngology-Head and Neck Surgery • Oct 1, 2014

  4. 4.
    Tinnitus

    NHS

  5. 5.
    Tinnitus: assessment and management - Recommendations (NG155)

    NICE • Mar 11, 2020

  6. 6.
    Tinnitus - topic summary

    NICE Clinical Knowledge Summaries • Apr 1, 2022

  7. 7.
    What Is Tinnitus? - Causes and Treatment

    National Institute on Deafness and Other Communication Disorders (National Institutes of Health) • May 1, 2023

  8. 8.
    Cognitive behavioural therapy for adults with tinnitus

    Cochrane • Jan 8, 2020

  9. 9.
    Deafness and hearing loss: Tinnitus

    World Health Organization

  10. 10.
    Tinnitus (JAMA Clinical Guidelines Synopsis)

    JAMA • May 24, 2016

Focus Areas

TinnitusHearing HealthEar RingingPulsatile TinnitusHearing LossSound TherapyCBTENT

Stay informed with the latest medical insights from MED.COM

Advertisement

Related Articles

ENT & Hearing Health

Hearing Loss in Adults: Early Signs and When to Get Checked

8 minOct 13, 2026

ENT & Hearing Health

Ear Infection in Adults: Symptoms, Causes, and When to See a Doctor

11 minOct 9, 2026

ENT & Hearing Health

Vertigo and BPPV: Symptoms, Causes, Treatment, and When to Get Help

9 minOct 19, 2026

ENT & Hearing Health

Sinusitis: Symptoms, Causes, and When to See a Doctor

7 minOct 12, 2026

Infectious Diseases

Measles Symptoms: Early Signs, the Rash and When to Get Help

9 minNov 22, 2026

Cardiology & Heart Health

Heart Attack Symptoms: Warning Signs and When to Call 999 or 911

9 minNov 21, 2026
MedCom

MED.COM is a curated medical knowledge platform.

Our content is designed to support understanding of medical fields, conditions, and developments — with clarity and professional standards.

contact@med.com

Platform

  • Medical Topics
  • About

Legal

  • Privacy Policy
  • Terms of Use
  • Accessibility
© 2026 MED.COM. All rights reserved.
Opt out of the sale or sharing of personal information

Opt out of the sale or sharing of personal information

We won't sell or share your personal information to inform the ads you see. You may still see interest-based ads if your information is sold or shared by other companies or was sold or shared previously.